Been another busy week across the small-cap sector, we are hearing that another broker company in London may be in trouble but we won’t comment until it is officially announced.
Integumen PLC (LON:SKIN) Highlands Nat. Resources agreement with Cellulac
Integumen notes Highlands agreement with Cellulac plc to supply hemp-derived CBD for medical-grade conversion Integumen to use Cellulac converted CBD for Its skincare and Wound pHase wound care products
Share Talk Weekly Stock Market News, 13th July 2019
Key Dates For Coming Week
Turner Pope Investments (TPI) latest research note on Integumen Plc (LON:SKIN)
As a function of the restructuring of the company since the end of 2018, Integumen has delivered a nine fold increase in revenue in H1 2019.
Share Talk Weekly Stock Market News, 3rd June 2019
It was another busy week in the junior markets for us, we caught up with Mick Billing, Executive Chairman of Thor Mining (ASX:LON; THR) who called into the studio to
Integumen PLC (LON:SKIN) Gerry Brandon
Integumen PLC’s (LON:SKIN) Gerry Brandon caught up with Proactive London’s Andrew Scott to discuss three new contracts they’ve won worth £290,000 in total.
Share Talk Weekly Stock Market News, 19th May 2019
It has been an interesting week across the markets as well lead up to the European elections here is the UK next week with sterling hitting a four year low.
Integumen PLC (LON:SKIN) CEO Gerry Brandon ‘ move into clinical trials.
Integumen PLC (LON:SKIN) CEO Gerry Brandon speaks to Proactive London’s Andrew Scott soon after announcing the roll-out of a new Labskin test designed to clone the skin of volunteers in clinical
Share Talk Weekly Stock Market News, 14th April 2019
It has been a crazy couple of week’s for the Share Talk team, we held investors show in London, at The Counting House located right in the heart of the
Integumen PLC (LON:SKIN) Chief Executive Gerry Brandon
Integumen builds out Labskin AI platform with RinoCloud acquisition
Integumen Plc (AIM:SKIN) LOI signed with Champion Shave
Integumen (LSE: SKIN), the personal health care company developing and commercialising technology and products for the human integumentary system, is pleased to announce it has on 21 December 2017 signed
